Independent research tool — not a government agency. Official notices govern.Refreshed
ForecastedResearch announcementOpportunity PAR-26-105

ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV

National Institutes of Health · Department of Health and Human Services

At a glance

ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV is a forecasted federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of September 25, 2026; forecast dates can change. Total estimated funding is $1.96M across about 4 awards. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.865 (Child Health and Human Development Extramural Research).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

  1. Feb 6, 2026Forecast posted
  2. Jul 24, 2026 (est.)Full notice expected
  3. Sep 25, 2026 (est.)Application deadline
  4. Jul 22, 2027 (est.)Est. award datenext date
Posted
Feb 6, 2026
Est. close date
Sep 25, 2026
Est. award date
Jul 22, 2027
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
$1,960,000
Implied average award
$490,000 calculated
Expected awards
4
Cost sharing
Not required
Funding instrument
Grant
Opportunity category
Discretionary
Fiscal year
FY2027

Typical awards for this program (SAM.gov listing for ALN 93.865, not this notice): For research project grants, fiscal year 2024, range is $50,000 to $5,000,000; average is $534,606. Individual research fellowship awards: Basic stipend (first year beyond the doctoral degree) of approximately $45,000. The sponsoring institution will be provided, on application, with an allowance of up to approximately $8,000 per year to help defray the cost of training. No dependency allowances. SBIR: Average Phase I awards are for approximately $225,000 (grant activity R43 - for up to six months); Phase II awards may be made for amounts up to $1,500,000 (grant activity R44 - for up to two years).

Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public colleges & universities
  • Federally recognized tribal governments
  • Public & Indian housing authorities
  • Native American tribal organizations
  • 501(c)(3) nonprofits
  • Nonprofits without 501(c)(3) status
  • Private colleges & universities
  • For-profit organizations (not small businesses)
  • Small businesses
  • Others (see notice)

Additional information on eligibility (from the notice)

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

NICHD will advance its mission by using the DP2 mechanism to support early-career investigators conducting pioneering research on HIV-related chronic conditions, coinfections, and comorbidities (3C). Scientific directions will be distinct from concepts and approaches already pursued and consistent with the scientific priorities of the Office of AIDS Research (OAR). HIV-related 3Cs cause significant and different pathology in people with and without HIV. Development of preventive and therapeutic strategies based on understanding HIV-specific pathways and mechanisms, and implementing those strategies is critical, especially in pediatric and maternal populations. All pediatric and maternal populations will be appropriate for study as the focus is on HIV prevention and/or treatment research.  A pipeline of innovative researchers from other fields of research including mathematics, engineering, computer science, and AI will bring new ideas and innovative approaches. This NOFO will advance research on an important public health problem by supporting transformative research on HIV 3Cs by investigators in the early stages of an independent career. 

How to apply

0 of 8 done · progress saved in this browser

Assistance Listing

What is an ALN?

Reported obligations under ALN 93.865

Historical data · not a prediction
FY24$1.28B
FY25$1.33B
FY26$185M est.
Source: SAM.gov Assistance Listing 93.865. Program-wide totals, not awards from this specific opportunity.

Who was funded under ALN 93.865

Historical data · not a prediction

Since October 1, 2023, 6,805 grant awards had funding actions under Child Health and Human Development Extramural Research, with 5,427 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.

  1. REGENTS OF THE UNIVERSITY OF MICHIGAN$111M
  2. UNIVERSITY OF WASHINGTON$99.9M
  3. THE JOHNS HOPKINS UNIVERSITY$92.1M
  4. REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE$77M
  5. TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE$74.4M
Recipients, states, recent awards and sub-awards →Source: USAspending.gov.

Agency contact (as published)

NICHD MPIDB
NICHD_MPIDB_Opportunities@mail.nih.gov
Please contact via e-mail

Quick answers

Is “ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV” open for applications yet?

Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around July 24, 2026. Forecast details and dates can change.

Who is eligible to apply for “ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV”?

The official notice names these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.

How much funding is available through “ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV”?

Per the notice, total estimated program funding is $1,960,000 and the agency expects to make about 4 awards.

How do I apply for “ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity PAR-26-105), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.